Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionHuman adenovirus type 26 vector carrying Zaire Ebola virus glycoprotein
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationEbola
Indication DetailsVaccinate against Ebola virus infection; Vaccinate against Ebola Zaire, Ebola Sudan and Marburg viruses
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today